Filing Details

Accession Number:
0001181431-13-028437
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-16 18:07:24
Reporting Period:
2013-05-14
Filing Date:
2013-05-16
Accepted Time:
2013-05-16 18:07:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534287 Bioamber Inc. BIOA.U Industrial Organic Chemicals (2860) 980601045
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1575522 Sicar Sca Partners Capital Naxos 40 Boulevard Joseph Ii, L-1840
N4
No No Yes No
1575936 S.a. Naxamber 40 Boulevard Joseph Ii, L-1840
N4
No No Yes No
1575976 R.l. S.a Managers Capital Naxos 40 Boulevard Joseph Ii
L-1840
N4
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-14 600,000 $0.00 3,970,815 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2013-05-14 600,000 $0.00 300,000 $11.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
600,000 2013-08-08 2017-05-09 No 4 P Direct
Footnotes
  1. The reported securities are included within 600,000 Units purchased by the reporting person for $10 per Unit in connection with the Issuer's initial public offering. Each Unit consists of one share of common stock and one warrant to purchase half of one share of common stock. The Units currently trade on the NYSE. The common stock and warrants comprising the Units will begin trading separately on June 10, 2013, at which time trading of the Units will be suspended and the Units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of common stock.
  2. Naxamber, S.A. ("Naxamber") directly owns 3,970,815 shares of Common Stock (inclusive of common stock included within 600,000 Units purchased). Naxamber is wholly-owned by Naxos Capital Partners SCA SICAR ("Naxos Partners"). The General Partner of Naxos Partners is Naxos Capital Managers S.a r.l. ("Naxos Managers"). Therefore, each of Naxamber, Naxos Partners and Naxos Managers may be deemed to beneficially own the shares of Common Stock directly owned by Naxamber.